Xinyi Huang | Obesity | Best Researcher Award

Dr. Xinyi Huang | Obesity | Best Researcher Award

Gaozhou people's hospital | China

Author Profile:

Orcid

🌟 DR. XINYI HUANG: A DEDICATED PHYSICIAN AND CARDIOVASCULAR RESEARCHER

🎓 EARLY ACADEMIC PURSUITS

Dr. Xinyi Huang began her medical journey at Guangdong Medical University, where she pursued a Bachelor of Medicine in Anesthesiology from 2015 to 2020. During her undergraduate years, she displayed exceptional academic prowess and leadership abilities. She actively participated in academic competitions, earning several accolades such as the Excellence Award in the 4th National Undergraduate Anesthesiology Knowledge Competition and multiple school-level awards in anesthesiology imaging professional skill contests.

Her strong academic foundation led her to further her studies at Sun Yat-sen University, one of China’s leading medical institutions. There, she specialized in Internal Medicine (Cardiovascular Medicine) and completed her Master of Medicine at Sun Yat-sen Memorial Hospital between 2020 and 2023.

🏥 PROFESSIONAL ENDEAVORS

Dr. Huang’s clinical career commenced as a Resident Doctor at Sun Yat-sen University, where she honed her expertise in cardiovascular medicine. Following this, she joined Gaozhou People's Hospital in Guangdong in October 2024, where she currently serves in the Cardiovascular Department.

Her clinical work focuses on the diagnosis and management of atrial fibrillation, obesity-related cardiovascular risks, and other complex cardiovascular conditions, reflecting her research interests.

🔬 CONTRIBUTIONS AND RESEARCH FOCUS ON OBESITY

Dr. Huang has actively contributed to the growing body of cardiovascular research. Her primary research areas include Atrial Fibrillation, particularly in patients with obesity and heart failure with preserved ejection fraction (HFpEF). She has co-authored significant academic papers addressing the association between body mass index (BMI), abdominal obesity, and the incidence of atrial fibrillation in heart failure patients.

Her research extends to exploring lipoprotein subgroups, such as HDL subtypes, and their influence on vascular inflammation in hypertensive patients, highlighting her multidisciplinary approach linking metabolism and cardiovascular health.

🌍 IMPACT AND INFLUENCE

Dr. Huang’s work contributes meaningfully to understanding how obesity and metabolic factors drive cardiovascular conditions like atrial fibrillation. Her research has been published in reputable journals such as Current Medical Research and Opinion and the Chinese Journal of Arteriosclerosis, enhancing clinical insights into cardiovascular disease prevention and management.

Her awards in anesthesiology and cardiovascular studies, along with her leadership roles and volunteer contributions, demonstrate her dedication to advancing both medical practice and community health.

📚 ACADEMIC CITES

Key Publications:

  1. Huang X, et al. “Association of Body Mass Index and Abdominal Obesity with Incidence of Atrial Fibrillation in Heart Failure with Preserved Ejection Fraction.” Current Medical Research and Opinion, 2025.

  2. Huang Jingjing, Huang Xinyi, et al. “Distribution of HDL Subgroups in Patients with H-type Hypertension and Its Impact on the Anti-inflammatory Function of Endothelial Cells.” Chinese Journal of Arteriosclerosis, 2023.

These publications are frequently cited by researchers exploring the links between metabolic dysfunction, arrhythmias, and cardiovascular inflammation.

🏅 AWARDS AND HONORS

  • Excellence Award, 4th National Undergraduate Anesthesiology Knowledge Competition (2018)

  • First Prize, Anesthesiology Imaging Professional Skills Competition Finals (2018)

  • Moral and Ethical Scholarship, Guangdong Medical University (2019)

  • Excellent Student Cadre, Guangdong Medical University (2017-2019)

  • Third-class Scholarship, Sun Yat-sen University (2020-2022)

  • Multiple awards recognizing her volunteerism, refereeing, and leadership contributions.

🌱 LEGACY AND FUTURE CONTRIBUTIONS

Looking ahead, Dr. Huang aspires to advance clinical strategies for obesity management in cardiovascular care, aiming to reduce the global burden of atrial fibrillation. She also seeks to explore AI-driven statistical tools and big data analytics to better predict cardiovascular outcomes.

With a strong passion for photography and life documentation, she continues to balance her rigorous scientific career with creative pursuits, inspiring a holistic approach to well-being and professional fulfillment.

📑 NOTABLE PUBLICATION

"Association of Body Mass Index and Abdominal Obesity with Incidence of Atrial Fibrillation in Heart Failure with Preserved Ejection Fraction"

Authors: Xinyi Huang; Xiao Liu; Yuan Jiang; Zhengyu Cao; Maoxiong Wu; Zhiteng Chen; Runlu Sun; Peng Yu; Jianyong Ma; Wengen Zhu
Journal: Current Medicinal Chemistry
Year: 2025

 

Wang Yanqiang | Atherosclerosis | Best Researcher Award

Prof. Wang Yanqiang | Atherosclerosis | Best Researcher Award

Prof. Wang Yanqiang, Department of Neurology Ⅱ, The Affiliated Hospital of Shandong Second Medical University, China

Prof. Wang Yanqiang is a distinguished neurologist currently serving in the Department of Neurology II at the Affiliated Hospital of Shandong Second Medical University, China. With a strong academic background, Prof. Wang earned his Master’s degree in Neurology from Xu Zhou Medical University and a Ph.D. from Sun Yat-sen University. His research primarily focuses on the pathogenesis and neuroprotection of ischemic brain injury, Parkinson’s disease, and other cerebrovascular disorders. Over the years, Prof. Wang has held various key positions, including roles as a resident and attending doctor at leading medical institutions in China.

AUTHOR PROFILE

Orcid Profile

🎓EARLY ACADEMIC PURSUITS:

Prof. Wang Yanqiang began his academic journey in the field of neurology, focusing on understanding the intricacies of neurological disorders and brain function. He pursued his medical education and specialized in neurology, laying the foundation for his future contributions in this domain. His early academic training focused on acquiring deep knowledge of neurophysiology, clinical neurology, and neuroanatomy, which would later guide his professional endeavors.

🏥PROFESSIONAL ENDEAVORS:

Prof. Wang Yanqiang holds a distinguished position at the Department of Neurology II at The Affiliated Hospital of Shandong Second Medical University, China. Over the years, he has been a leading figure in both clinical practice and medical research. He has worked tirelessly in patient care, offering specialized neurological treatments and providing critical insights into various neurological conditions. His professional endeavors also include educating and mentoring students, fostering the next generation of neurologists, and playing a key role in advancing clinical practices within the medical community.

🔬CONTRIBUTIONS AND RESEARCH FOCUS ON Atherosclerosis

Prof. Wang Yanqiang’s research primarily revolves around neurological disorders, with a particular focus on neurodegenerative diseases, cerebrovascular disorders, and epilepsy. His contributions to the understanding of these diseases have led to significant advancements in both diagnostic techniques and treatment methodologies. His research also spans neuroplasticity, neuroinflammation, and neuroprotective strategies, aiming to develop better therapeutic approaches for patients suffering from neurological impairments. Additionally, Prof. Wang has contributed to the development of diagnostic tools that have improved clinical outcomes in neurology.

🌍IMPACT AND INFLUENCE:

Prof. Wang Yanqiang’s work has had a profound impact on the field of neurology in both China and internationally. His contributions to the understanding of complex neurological diseases have shaped modern clinical practices and research initiatives. His publications and research findings have influenced treatment protocols and inspired further studies in neurodegenerative and cerebrovascular diseases. As a prominent figure in neurology, Prof. Wang has served as a role model for younger neurologists, encouraging a new wave of innovative thinking and patient-centered care in neurology.

📚ACADEMIC CITATIONS AND RECOGNITION:

Prof. Wang Yanqiang’s research has been widely recognized and cited within the academic community. His articles and studies are frequently cited in major neurological journals, reflecting the significance of his work in advancing scientific knowledge in neurology. His contributions have earned him a reputation as a leading expert in the field, with many of his works becoming foundational references for ongoing research. His academic influence is evidenced not only by citations but also through his collaborations with prominent neurologists worldwide.

🌟LEGACY AND FUTURE CONTRIBUTIONS:

Prof. Wang Yanqiang’s legacy in the field of neurology is marked by his groundbreaking research, dedication to patient care, and commitment to advancing the field. His work has contributed to a better understanding of neurological diseases and has paved the way for innovative treatments. As the field of neurology continues to evolve, Prof. Wang’s influence will likely continue to shape future developments in both clinical practice and medical research. His legacy also includes the mentorship of future generations of neurologists, ensuring that his impact on the field will extend far beyond his career.

🚀CONCLUSION:

Prof. Wang Yanqiang is an esteemed neurologist whose research has greatly advanced our understanding of ischemic brain injury, Parkinson’s disease, and cerebrovascular disorders. With a rich academic background and extensive clinical experience, his contributions to neuroprotection and molecular mechanisms are highly impactful. Through his numerous publications, Prof. Wang has gained international recognition for his work, which continues to influence the field of neurology. His dedication to improving patient outcomes and advancing neurological research makes him a true leader in the medical community.

TOP NOTABLE PUBLICATIONS

  • Title: Inhibition of the cGAS–STING pathway: contributing to the treatment of cerebral ischemia-reperfusion injury

    • Journal: Neural Regeneration Research
    • Volume: 2025-07
    • Year: 2025
  • Title: Exploring the Neuroprotective Effects of Lithium in Ischemic Stroke: A literature review

    • Journal: International Journal of Medical Sciences
    • Volume: 2024
    • Year: 2024
  • Title: Risk Factors and Clinical Characteristics of First-ever Ischemic Stroke Caused by ICAS with Leukoaraiosis

    • Journal: International Journal of Medical Sciences
    • Volume: 2024
    • Year: 2024
  • Title: 1,25-D3 ameliorates ischemic brain injury by alleviating endoplasmic reticulum stress and ferroptosis: Involvement of vitamin D receptor and p53 signaling

    • Journal: Cellular Signalling
    • Volume: 2024-10
    • Year: 2024
  • Title: A case of acute basilar artery occlusion due to atherosclerotic disease revascularized by drug-coated balloon dilation

    • Journal: International Journal of Neuroscience
    • Volume: 2024-09
    • Year: 2024
  • Title: A case report of drug-coated balloon dilation angioplasty in a patient with acute atherosclerotic basilar artery occlusion

    • Journal: Asian Journal of Surgery
    • Volume: 2024-09
    • Year: 2024
  • Title: Global, regional, and national epidemiology of ischemic stroke from 1990 to 2021

    • Journal: European Journal of Neurology
    • Volume: 2024-09-17
    • Year: 2024
  • Title: Genetic insights into the relationship between immune cell characteristics and ischemic stroke: A bidirectional Mendelian randomization study

    • Journal: European Journal of Neurology
    • Volume: 2024-05
    • Year: 2024
  • Title: Assessing tobacco-related ischemic stroke in Pakistan (1990-2019): Insights from the Global Burden of Disease Study

    • Journal: Tobacco Induced Diseases
    • Volume: 2024-03-28
    • Year: 2024
  • Title: First report of a p.Cys484Tyr Notch3 mutation in a CADASIL patient with acute bilateral multiple subcortical infarcts—case report and brief review

    • Journal: BMC Neurology
    • Year: 2024